Treatment gap in the use of lipid-lowering drug therapy in diabetes: A population-based study

Diabetic Medicine

Volumn 21, Issue 10, 2004, Pages 1108-1112

  James, Peter ^a   Tan, H H ^b   MacAlpine, R ^a   Brennan, G ^a   Emslie Smith, A ^a   Morris, A D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b SINGHEALTH POLYCLINICS   (Singapore)

Author keywords

Diabetes; Lipid lowering drug therapy; Uptake

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREVALENCE; SMOKING; UNITED KINGDOM;

ADULT; AGED; ANTILIPEMIC AGENTS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; SCOTLAND;

EID: 6344280446     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01301.x     Document Type: Article

References (19)

1. Castelli WP. Making practical sense of clinical trials data in decreasing cardiovascular risk. Am J Cardiol 2001; 88: 16F-20F.
2. Heart Protection Study Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo control trial. Lancet 2002; 360: 7-22.
3. Isles CG. Patients with acute coronary syndrome should start a statin while still in hospital. Heart 2002; 88: 5-6.
4. Norhammer A, Malmberg K, Ryden L, Tornvall P, Stenestrand U, Wallentin L. Underutilisation of evidence-based treatment partial explanation for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 2003; 24: 838-844.
5. EUROSPIRE Study Group. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J 1997; 18: 1569-1582.
6. Bowker TJ, Clayton TC, Ingham JE, McLennan NR, Hobson HL, Pyke SD et al. A British Cardiac Society Survey of the potential for secondary prevention of coronary disease-'ASPIRE'. Heart 1996; 75: 334-342.
7. Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP): a multicentre survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein in cholesterol goals. Arch Intern Med 2000; 160: 459-467.
8. National Cholesterol Education Program (NCEP) Expert Panel. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
9. Morris A, Boyle DIR, MacAlpine R, Emslie-Smith A, Jung RT, Newton RW et al. for the DARTS/MEMO collaboration. The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. BMJ 1997; 315: 524-8.
10. SIGN Administrative Support Group. SIGN publication. Report on a Recommended Minimal Dataset for Collection in People with Diabetes. Edinburgh: Scottish Intercollegiate Guidelines Network, Royal College of Physicians, 1998.
11. Paladino JA. Pharmaceutical care at Tayside, Scotlan. Ann Pharmacother 1994; 28: 120.
12. Carstairs V. Deprivation and health in Scotland. Health Bull (Edinb) 1990; 48: 162-175.
13. Reid FDA, Cook DG, Whincup PH. Use of statins in the secondary prevention of coronary heart disease: is treatment equitable? Heart 2002; 88: 15-19.
14. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Eur Heart J 2001; 22: 554-572.
15. Whincup PH, Emberson JR, Lennon L, Walker M, Papacosta O, Thomson A. Low prevalence of lipid lowering drug use in older men with established coronary heart disease. Heart 2002; 88: 25-29.
16. DeWilde S, Carey IM, Bremner SA, Richards N, Hilton SR, Cook DG. Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? Heart 2003; 89: 417-421.
17. Shepherd J. Issues surrounding age: vascular disease in the elderly. Curr Opin Lipidol 2001; 12: 601-609.
18. Wei L, Wang J, Thompson P, Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients after myocardial infarction: a six-year follow-up study. Heart 2002; 88: 229-233.
19. Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med 2002; 19: 279-284.